NK105

· Nippon Kayaku Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NK105, covering 2019-07-29 to 2019-07-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of NK105 in Patients With Breast Cancer [Phase 3]